Inovio Pharmaceuticals to Present at s "Future Leaders in the Biotech Industry" Conference

Its SynConA vaccines are designed to provide universal cross-strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza.

http://www.biospace.com/news_story.aspx?StoryID=291766&full=1